$AFJK·8-K

Aimei Health Technology Co., Ltd. · Jun 4, 4:05 PM ET

Compare

Aimei Health Technology Co., Ltd. 8-K

Research Summary

AI-generated summary

Updated

Aimei Health Extends SPAC Termination Date, Issues $34.33K Promissory Note

What Happened

  • Aimei Health Technology Co., Ltd. filed an 8‑K (June 4, 2026) announcing a one‑month extension of its SPAC termination date from June 6, 2026 to July 6, 2026. A total of $34,330.96 (the “Extension Payment”) was deposited into the company’s public shareholders’ trust account to effect the extension — the nineteenth extension permitted under the company’s current Amended and Restated Articles of Association.
  • To fund that Extension Payment, the company issued an unsecured promissory note dated June 4, 2026, in the principal amount of $34,330.96 to Aimei Health Ltd (the Sponsor) and United Hydrogen Group Inc. (together, the Payees).

Key Details

  • Extension amount deposited: $34,330.96 (represents the lesser of $80,000 total or $0.033 per outstanding public share per monthly extension).
  • New Termination Date: July 6, 2026 (extension from June 6, 2026).
  • Promissory Note: $34,330.96 principal, split equally ($17,165.48) to each Payee; unsecured, non‑interest bearing; principal due when the business combination with United Hydrogen closes.
  • Conversion right: Payees may (but are not required to) convert the note, in whole or part, into private units at $10.00 per unit (each unit = one ordinary share plus a right to 1/5 of an ordinary share) by giving at least two business days’ written notice before closing.

Why It Matters

  • The filing extends the deadline for Aimei Health to complete its initial business combination, giving the SPAC one more month to close a deal. Repeated extensions indicate the company has repeatedly delayed finalizing a business combination.
  • The promissory note creates a direct financial obligation that becomes due at closing; it is small in dollar terms but could convert into private units, which would dilute existing shareholders if conversion occurs.
  • The note is unsecured and non‑interest bearing and gives the Sponsor and United Hydrogen optional conversion rights, so investors should monitor future filings for any conversion, repayment, or further extensions.

Loading document...